Understanding the benefits of GLP-1 drugs beyond obesity
In a Perspective, Daniel Drucker highlights the growing body of evidence that hints at the potential of glucagon-like peptide-1 (GLP-1)-based medications in treating conditions other than diabetes and obesity, including…
Proteins and fats can drive insulin production for some, paving way for tailored nutrition
When it comes to managing blood sugar levels, most people think about counting carbs. But new research from the University of British Columbia shows that, for some, it may be…